TFAP2C and breast cancer: Western blot analysis demonstrated that TFAP2C knockdown led to a reduction in the expression of YAP, p-YAP, and β-catenin proteins, indicating a connection between TFAP2C and these pathways in mediating drug resistance in BC (Fig. 6H).